Skip to main content
Livermore
Livermore
ZHEN

Blueprint Medicines Corp

BPMCDelisted Jul 18, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001597264

Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.

Q3 2024 vs. Q2 2024

How the institutions holding Blueprint Medicines Corp changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of BPMC: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders3053319+17
Shares66.3M6.65M65.3M+5.64M (+9.5%)
Value$7.15B$717.0M$6.04B−$388.8M (−6.0%)

3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (56)

Institutions that held Blueprint Medicines Corp at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to BPMC in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.7,119,049$658.5M0.01%
Squarepoint Ops LLC224,210$20.7M0.07%
M&G Plc97,861$9.10M0.05%
Ikarian Capital, LLC85,000$7.86M2.44%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.69,887$6.46M0.02%
Readystate Asset Management LP56,500$5.23M0.27%
Group One Trading, L.P.50,461$4.67M0.18%
Prosight Management, LP47,100$4.36M1.10%
Seven Eight Capital, LP38,134$3.53M0.32%
Exome Asset Management LLC36,700$3.39M2.29%
Essex Investment Management Co LLC35,461$3.28M0.57%
Boothbay Fund Management, LLC24,862$2.30M0.07%
Balyasny Asset Management LLC23,750$2.20M0.01%
Zimmer Partners, LP21,100$1.95M0.04%
PEAK6 Investments LLC20,893$1.93M0.10%
Intech Investment Management LLC18,511$1.71M0.02%
HRT Financial LP17,085$1.58M0.01%
CenterBook Partners LP14,528$1.34M0.08%
Jump Financial, LLC12,704$1.18M0.02%
Twin Tree Management, LP11,954$1.11M0.03%
Inceptionr LLC11,642$1.08M0.26%
Entropy Technologies, LP10,800$999.0K0.10%
Dark Forest Capital Management LP10,348$957.2K0.12%
Prelude Capital Management, LLC10,220$945.4K0.07%
DnB Asset Management AS8,713$806.0K0.00%
New York Life Investment Management LLC7,173$663.5K0.01%
Nebula Research & Development LLC6,529$603.9K0.07%
Illinois Municipal Retirement Fund6,159$569.7K0.01%
Bridgefront Capital, LLC6,063$560.8K0.22%
Connor, Clark & Lunn Investment Management Ltd.5,132$474.7K0.00%
ADAR1 Capital Management, LLC5,100$471.8K0.08%
Acadian Asset Management LLC3,934$363.0K0.00%
Sherbrooke Park Advisers LLC3,113$288.0K0.07%
Corton Capital Inc.3,058$282.9K0.14%
Blueshift Asset Management, LLC2,998$277.3K0.07%
Fox Run Management, L.L.C.2,830$261.8K0.06%
Birchview Capital, LP2,700$249.8K0.22%
Teamwork Financial Advisors, LLC2,700$249.8K0.03%
Valence8 US LP2,618$242.2K0.11%
Fiduciary Family Office, LLC2,300$212.8K0.07%
JGP Global Gestao de Recursos Ltda.2,204$203.9K0.40%
Sanctuary Advisors, LLC2,144$201.9K0.00%
Ci Investments Inc.1,472$136.0K0.00%
Values First Advisors, Inc.1,315$121.7K0.07%
Quantbot Technologies LP1,164$107.7K0.00%
Danske Bank A/S1,100$101.8K0.00%
Quarry LP350$32.4K0.01%
True Wealth Design, LLC135$12.5K0.00%
Truvestments Capital LLC98$9.06K0.00%
Sterling Capital Management LLC64$5.92K0.00%
Capital Performance Advisors LLP41$3.79K0.00%
Picton Mahoney Asset Management25$2.00K0.00%
TD Waterhouse Canada Inc.21$1.89K0.00%
Principal Securities, Inc.19$1.76K0.00%
Wolff Wiese Magana LLC19$1.76K0.00%
Bryn Mawr Trust Co5$4630.00%

Sold out (39)

Institutions that held Blueprint Medicines Corp at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of BPMC in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
1832 Asset Management L.P.502,651$54.2M
Point72 Asset Management, L.P.501,581$54.1M
Driehaus Capital Management LLC358,255$38.6M
Redmile Group, LLC94,405$10.2M
Candriam Luxembourg S.C.A.52,066$5.61M
EAM Global Investors LLC41,242$4.45M
Nicholas Investment Partners, LP40,611$4.38M
Susquehanna Portfolio Strategies, LLC40,277$4.34M
Harbor Capital Advisors, Inc.23,978$2.58M
Point72 Europe (London) LLP13,569$1.46M
O'Neil Global Advisors, Inc.13,283$1.43M
Bayesian Capital Management, LP12,243$1.32M
Capula Management Ltd7,939$855.7K
Gsa Capital Partners LLP7,444$802.0K
Calamos Advisors LLC7,022$756.8K
Ellsworth Advisors, LLC5,173$557.5K
Legato Capital Management LLC5,165$556.7K
Cubist Systematic Strategies, LLC4,901$528.2K
Alpha DNA Investment Management LLC3,879$418.1K
Crossmark Global Holdings, Inc.3,533$381.0K
Baader Bank INC3,498$371.1K
Point72 Hong Kong Ltd3,339$359.8K
Stephens Inc3,322$358.0K
nVerses Capital, LLC3,200$344.9K
Simplex Trading, LLC2,724$293.0K
Nomura Holdings Inc2,506$270.1K
Pinnacle Wealth Planning Services, Inc.1,965$211.8K
Atria Investments LLC1,940$209.1K
Virtus Investment Advisers, Inc.758$81.7K
Allianz SE700$75.4K
Pacer Advisors, Inc.540$58.2K
Triad Wealth Partners, LLC250$26.9K
SYSTM Wealth Solutions LLC237$25.5K
Redwood Wealth Management Group, LLC212$22.8K
Virtus Fund Advisers, LLC147$15.8K
Macroview Investment Management LLC70$7.54K
Itau Unibanco Holding S.A.50$5.39K
Stephens Consulting, LLC33$3.56K
Innealta Capital, LLC6$647

Not filed for Q3 2024 yet (3)

Institutions that held Blueprint Medicines Corp at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BPMC in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.6,647,297$716.4M
Susquehanna Fundamental Investments, LLC5,000$538.9K
Institutional & Family Asset Management, LLC9$970